These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36647948)

  • 1. Analysis of risk factors related to acute radiation dermatitis in breast cancer patients during radiotherapy.
    Liu D; Zheng Z; Zhang S; Zhu C; Zhang H; Zhou Y
    J Cancer Res Ther; 2022 Dec; 18(7):1903-1909. PubMed ID: 36647948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis.
    Pignol JP; Olivotto I; Rakovitch E; Gardner S; Sixel K; Beckham W; Vu TT; Truong P; Ackerman I; Paszat L
    J Clin Oncol; 2008 May; 26(13):2085-92. PubMed ID: 18285602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer.
    Krug D; Köder C; Häfner MF; Arians N; Harrabi SB; Koerber SA; Forster T; Schlampp I; Sohn C; Heil J; Hof H; Hörner-Rieber J; Debus J
    Radiat Oncol; 2020 Oct; 15(1):235. PubMed ID: 33050920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation.
    Ho AY; Olm-Shipman M; Zhang Z; Siu CT; Wilgucki M; Phung A; Arnold BB; Porinchak M; Lacouture M; McCormick B; Powell SN; Gelblum DY
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):325-333. PubMed ID: 29726361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
    Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E
    Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial.
    Krug D; Baumann R; Krockenberger K; Vonthein R; Schreiber A; Boicev A; Würschmidt F; Weinstrauch E; Eilf K; Andreas P; Höller U; Dinges S; Piefel K; Zimmer J; Dellas K; Dunst J
    Strahlenther Onkol; 2021 Jan; 197(1):48-55. PubMed ID: 33001241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity modulated radiotherapy with simultaneous integrated boost vs. conventional radiotherapy with sequential boost for breast cancer - A preliminary result.
    Lee HH; Hou MF; Chuang HY; Huang MY; Tsuei LP; Chen FM; Ou-Yang F; Huang CJ
    Breast; 2015 Oct; 24(5):656-60. PubMed ID: 26371691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin-sparing intensity-modulated radiotherapy of the breast.
    Vordermark D
    J Clin Oncol; 2008 Jul; 26(19):3292; author reply 3292-3. PubMed ID: 18591570
    [No Abstract]   [Full Text] [Related]  

  • 9. Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer.
    Freedman GM; Anderson PR; Li J; Eisenberg DF; Hanlon AL; Wang L; Nicolaou N
    Am J Clin Oncol; 2006 Feb; 29(1):66-70. PubMed ID: 16462506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors modifying the risk for developing acute skin toxicity after whole-breast intensity modulated radiotherapy.
    De Langhe S; Mulliez T; Veldeman L; Remouchamps V; van Greveling A; Gilsoul M; De Schepper E; De Ruyck K; De Neve W; Thierens H
    BMC Cancer; 2014 Sep; 14():711. PubMed ID: 25252713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective study of radiotherapy-induced skin reactions in breast cancer patients: reduced incidence of moist desquamation with a hydroactive colloid gel versus dexpanthenol.
    Censabella S; Claes S; Orlandini M; Braekers R; Thijs H; Bulens P
    Eur J Oncol Nurs; 2014 Oct; 18(5):499-504. PubMed ID: 24877859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical skin measurements to evaluate the effectiveness of photobiomodulation therapy in the prevention of acute radiation dermatitis in breast cancer patients.
    Robijns J; Censabella S; Claes S; Pannekoeke L; Bussé L; Colson D; Kaminski I; Lodewijckx J; Bulens P; Maes A; Noé L; Brosens M; Timmermans A; Lambrichts I; Somers V; Mebis J
    Support Care Cancer; 2019 Apr; 27(4):1245-1254. PubMed ID: 30270415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of topical timolol for the prevention of radiation-induced dermatitis in breast cancer: a pilot triple-blind, placebo-controlled trial.
    Nabi-Meybodi M; Sahebnasagh A; Hakimi Z; Shabani M; Shakeri AA; Saghafi F
    BMC Cancer; 2022 Oct; 22(1):1079. PubMed ID: 36266613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of acute toxicities between contemporary forward-planned 3D conformal radiotherapy and inverse-planned intensity-modulated radiotherapy for whole breast radiation.
    Guttmann DM; Gabriel P; Kennedy C; Rate W; Grizos W; Nagda S; Wojtowicz L; Lin L; Freedman GM
    Breast J; 2018 Mar; 24(2):128-132. PubMed ID: 28703444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of postoperative radiotherapy-induced acute dermatitis in breast cancer and its influencing factors for Chinese women.
    Ding J; Guo Y; Li Q; Chen J; Hu P; Liu Q; Cao Y; Wu J
    Onco Targets Ther; 2018; 11():1665-1670. PubMed ID: 29615841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].
    Liem X; Chira C; Fourquet A; Campana F; Peurien D; Fournier-Bidoz N; Kirova YM
    Cancer Radiother; 2014 Jan; 18(1):15-22. PubMed ID: 24316350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting acute radiation dermatitis in breast cancer: a prospective cohort study.
    Xie Y; Hu T; Chen R; Chang H; Wang Q; Cheng J
    BMC Cancer; 2023 Jun; 23(1):537. PubMed ID: 37308936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships among patient characteristics, irradiation treatment planning parameters, and treatment toxicity of acute radiation dermatitis after breast hybrid intensity modulation radiation therapy.
    Lee TF; Sung KC; Chao PJ; Huang YJ; Lan JH; Wu HY; Chang L; Ting HM
    PLoS One; 2018; 13(7):e0200192. PubMed ID: 30011291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute toxicity of breast cancer irradiation with modulated intensity by tomotherapy
    Aoulad N; Massabeau C; de Lafontan B; Vieillevigne L; Hangard G; Ciprian C; Chaltiel L; Moyal É; Izar F
    Cancer Radiother; 2017 May; 21(3):180-189. PubMed ID: 28499662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should intensity-modulated radiation therapy be the standard of care in the conservatively managed breast cancer patient?
    Haffty BG; Buchholz TA; McCormick B
    J Clin Oncol; 2008 May; 26(13):2072-4. PubMed ID: 18285600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.